ROSSARI BIOTECH
ROSSARI · NSE
407.60
-0.80 (-0.20%)
as of 29 Oct 2026 close
Open
414.00
High
414.00
Low
405.00
Prev close
408.40
52w high
656.05
29 Oct 2025
52w low
375.00
30 Mar 2026
VWAP
408.59
Delivery %
49.0%
of volume
Volume 49,434 · turnover ₹2.02 Cr · NSE bhavcopy (official close) · history since 23 Jul 2020
- ISIN
- INE02A801020
- Series
- EQ
- Listed on NSE
- 23 Jul 2020
- Face value
- ₹2
- F&O
- No
Source: NSE equity master · as of 30 Oct 2026
Daily · NSE EOD
Quarterly results · Standalone · latest 30 Sept 2026
filed 17 Oct 2026, 08:38 pm IST| ₹ crore | Sept 26* |
|---|---|
| Revenue | 495 |
| Other income | 2 |
| Total expenses | 451 |
| Operating margin | 11.6% |
| Finance costs | 2 |
| Depreciation | 11 |
| Profit before tax | 46 |
| Tax | 12 |
| Net profit | 34 |
| Net margin | 6.9% |
| EPS (₹) | 6.18 |
Source and definitions
NSE financial-results filings (XBRL / integrated filing). Figures exactly as filed with NSE in the company's results, converted to ₹ crore from the filing's own rounding. Operating margin = (PBT + finance costs + depreciation − other income) ÷ revenue. Net margin = net profit ÷ revenue. * = unaudited quarter. Consolidated figures are shown when the company files them; otherwise standalone.
Coming next in fundamentals
Arrives in Phase 2. Nothing here is estimated or filled in — we only show data we have.
- P/E, P/B, EV/EBITDA, ROE, ROCE (needs balance sheet + market cap)
- FII / DII / mutual fund split (from shareholding XBRL)
- Peer comparison